Prodromal Parkinson's disease: hype or hope for disease-modification trials?

Overview of attention for article published in Translational Neurodegeneration, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

twitter: 5 X users

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 63 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 21,258 followers.

Thanks for sharing @AbhiLenka11 @MDCP_Journal

09 May 2022

Reply Repost Favourite

A useful new review covers recruitment strategies for disease-modification trials in various prodromal #Parkinsons cohorts, as well as potential trial designs, required trial durations, & estimated sample sizes https://t.co/5bsu9zOC27 https://t.co/WMH1

23 Feb 2022

Reply Repost Favourite

RT @Ingentium_PD: Prodromal Parkinson's disease: hype or hope for disease-modification trials? https://t.co/hf9CNKh9TF https://t.co/2MSWF57…

23 Feb 2022

Reply Repost Favourite

Prodromal Parkinson's disease: hype or hope for disease-modification trials? https://t.co/hf9CNKh9TF https://t.co/2MSWF57I4r

23 Feb 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.